Literature DB >> 453326

Atrioventricular canal malformation interpreted as secondary to reduced compression upon the developing heart.

G M Hutchins, L Liebman, G W Moore, F Gharagozloo.   

Abstract

This study was undertaken to evaluate the nature and pathogenesis of malformations of the atrioventricular canal in relation to normal cardiogenesis. Serial histologic sections of normal human embryos and fetuses were made, from which three-dimensional images were reconstructed to show the relationship between the developing heart and its surrounding structures, and the course of development of the atrial septum and atrioventricular valves. Based on these reconstructions and on examination of the hearts of 59 patients with atrioventricular canal malformations, it is suggested that the spectrum of atrioventricular malformations may arise as a result of reduced compression of the developing atria by surrounding structures during embryonic Stages 13 through 18. Comparison of hearts with atrioventricular canal defects with normal embryos indicated that the malformations may be classified as primitive canals, complete canals, or partial canals, corresponding to failure of completion of normal development in Stages 14 through 18. In primitive canal the atrial septum was absent or had only a portion of septum primum. In complete canal both atrial septums were present, but the atrioventricular valve material was not subdivided and the four chambers were in communication. In partial canal, the atrioventricular valve was divided, but atrial and ventricular septal defects and valve clefts were present in varying degrees of severity. It is proposed that the spectrum of cardiac abnormalities which constitutes atrioventricular canal malformations may be understood as arising from varying degrees of lack of normal compression of the developing heart by surrounding structures. (Am J Pathol 95.579-598, 1979)

Entities:  

Mesh:

Year:  1979        PMID: 453326      PMCID: PMC2042307     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  15 in total

1.  The anatomy and embryology of endocardial cushion defects.

Authors:  L H VAN MIEROP; R D ALLEY; H W KAUSEL; A STRANAHAN
Journal:  J Thorac Cardiovasc Surg       Date:  1962-01       Impact factor: 5.209

2.  Endocardial cushion defects; common atrio-ventricular canal and ostium primum.

Authors:  M CAMPBELL; G A MISSEN
Journal:  Br Heart J       Date:  1957-07

3.  Developmental and pathologic considerations in persistent common atrioventricular canal.

Authors:  J E EDWARDS; C S WAKAI
Journal:  Proc Staff Meet Mayo Clin       Date:  1956-09-05

4.  A proposed pathogenesis of cor triatriatum: impingement of the left superior vena cava on the developing left atrium.

Authors:  F Gharagozloo; B H Bulkley; G M Hutchins
Journal:  Am Heart J       Date:  1977-11       Impact factor: 4.749

5.  Certainty levels in the nullity method of symbolic logic: application to the pathogenesis of congenital heart malformations.

Authors:  G W Moore; G M Hutchins; B H Bulkley
Journal:  J Theor Biol       Date:  1979-01-07       Impact factor: 2.691

6.  The pathogenesis of tetralogy of Fallot.

Authors:  K J Winn; G M Hutchins
Journal:  Am J Pathol       Date:  1973-10       Impact factor: 4.307

7.  An analysis of 35 cases of the complete form of persistent common atrioventricular canal.

Authors:  L Tenckhoff; S J Stamm
Journal:  Circulation       Date:  1973-08       Impact factor: 29.690

8.  Truncus arteriosus malformation in a human embryo.

Authors:  B J Maron; G M Hutchins
Journal:  Am J Anat       Date:  1972-06

9.  Juxtaposition of atrial appendages. Reinterpretation as an accessory appendage or atrial diverticulum.

Authors:  G Mendelsohn; G M Hutchins
Journal:  Arch Pathol Lab Med       Date:  1977-09       Impact factor: 5.534

10.  Association of interrupted aortic arch with malformations producing reduced blood flow to the fourth aortic arches.

Authors:  G W Moore; G M Hutchins
Journal:  Am J Cardiol       Date:  1978-09       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.